Skip navigation
Skip navigation

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment

Ralph, Anna P; Yeo, Tsin W.; Salome, Cheryl; Waramori, G; Pontororing, Gysje J; Kenangalem, Enny; Sandjaja, .; Tjitra, Emiliana; Lumb, Richard; Maguire, Graeme P.; Price, Ric N; Chatfield, Mark D; Kelly, Paul; Anstey, Nicholas

Description

Background. Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) and

CollectionsANU Research Publications
Date published: 2013
Type: Journal article
URI: http://hdl.handle.net/1885/74015
Source: International Journal of Infectious diseases
DOI: 10.1093/infdis/jit248

Download

File Description SizeFormat Image
01_Ralph_Impaired_pulmonary_nitric_2013.pdf748 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator